Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations

Sarah Ringold1, Kristy D Seidel, Thomas D Koepsell

  • 1Division of Rheumatology, University of Washington and Seattle Children's Hospital, Seattle, WA 98105, USA. sarah.ringold@seattlechildrens.org

Insights

Children with polyarticular juvenile idiopathic arthritis (JIA) often experience active disease. Early joint damage and RF(+) status are linked to more active disease, suggesting these subgroups need targeted interventions for better outcomes.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Clinical Medicine

Background:

  • Polyarticular juvenile idiopathic arthritis (JIA) is a chronic autoimmune condition affecting multiple joints in children.
  • Achieving inactive disease (ID) and remission are key treatment goals in pediatric rheumatology.
  • Understanding factors associated with disease activity is crucial for optimizing JIA management.

Purpose of the Study:

  • To determine the rates of inactive disease and remission in children with polyarticular JIA.
  • To investigate associations between patient characteristics, imaging findings, and disease activity outcomes.
  • To identify subgroups of JIA patients with higher disease burden.

Main Methods:

  • Retrospective cohort study of 104 children with polyarticular JIA.
  • Disease status (active disease vs. ID) assessed at each clinic visit over an average 30-month follow-up.
  • Mantel-Haenszel methods used to calculate adjusted relative risk estimates.

Main Results:

  • Patients spent a mean of 66.3% of follow-up with active disease.
  • Children with early joint damage on imaging had significantly more active disease (79% vs. 58.5%, P < 0.001).
  • Rheumatoid factor positive (RF(+)) status and early joint damage were associated with higher active disease prevalence.

Conclusions:

  • The majority of the follow-up period for children with polyarticular JIA is characterized by active disease.
  • Early radiographic evidence of joint damage and RF(+) status identify high-risk subgroups requiring focused therapeutic strategies.
  • Improving outcomes for these specific JIA patient subgroups should be a priority for future research and clinical practice.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...